We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Innovative Cardiac Monitoring System to Transform Heart Failure Care

By HospiMedica International staff writers
Posted on 27 Dec 2024
Print article
Image: The patented methodology helps know a patient’s hemodynamics non-invasively, faster and more accurately (Photo courtesy of SeeMedX)
Image: The patented methodology helps know a patient’s hemodynamics non-invasively, faster and more accurately (Photo courtesy of SeeMedX)

Healthcare providers managing heart failure patients often have limited treatment options, most of which are invasive, high-risk, and expensive. Now, a groundbreaking, non-invasive technology offers real-time insights into cardiac function and fluid status, allowing clinicians to optimize treatment for heart failure much earlier, ultimately improving patient outcomes.

SeeMedX (Las Vegas, NV, USA) has introduced an advanced, non-invasive cardiac monitoring device that provides healthcare professionals with real-time data on cardiac performance and fluid status. This technology helps clinicians make well-informed decisions, enabling faster and safer optimization of heart failure treatment compared to traditional methods. SeeMedX's device offers precise hemodynamic measurements, including Zo (fluid status) and CO (cardiac output), which help detect volume overload and other symptoms of heart failure earlier than conventional techniques. By delivering actionable data on Zo and CO, the device allows clinicians to make timely decisions that improve heart failure management.

The non-invasive nature of the device ensures a painless experience, enhancing both patient comfort and clinical workflow efficiency. It facilitates faster interventions, improving hospital operations and supporting timely clinical decisions. SeeMedX has filed a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA) for its cardiac monitoring device. With over 6 million Americans suffering from heart failure, costing the healthcare system more than USD 30 billion each year, SeeMedX's solution addresses a critical need. Pending FDA clearance, SeeMedX is preparing for a U.S. market launch and plans to seek regulatory approvals in additional global markets.

"This submission marks a major milestone for SeeMedX in advancing heart failure care," said Deborah Simpson, CEO of SeeMedX. "Our goal is to empower clinicians with tools that ultimately improve outcomes for patients everywhere."

Related Links:
SeeMedX

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
12-Channel ECG
CM1200B
New
Shoulder Positioner
HE-JB2
New
Catheters
Camino 1104B Series

Print article

Channels

Surgical Techniques

view channel
Image: The implantable wireless sensors can read and transmit patients\' parameters via ultrasound (Photo courtesy of Microtech)

Microsensor Platform Turns Existing Implants into Smart Devices for Real Time Monitoring

A revolutionary technology allows for the integration of sensors into existing medical devices, enabling physicians to monitor patients' vital signs in real time and make treatment decisions based on measurable... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.